Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...

World Cup 2026 kicks off tonight, which means getting the office sweepstakes in is paramount. This is simply the most ambitious World Cup to date and promises to be bigger than ever. For the first ...

Nothing in sport stirs up excitement quite like a World Cup. We're barely a week away from the 2026 edition kicking off, and it's high time to start sorting out those office sweepstakes. Put simply, ...

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

A lot of thought goes into naming a racehorse. Some people take inspiration from the horse’s pedigree, while others make it more personal, naming the horse after something special to the owner: a ...

One of the best parts of the Kentucky Derby is listening to Travis Stone, the Churchill Downs Racetrack announcer, rapidly list off the name of each Kentucky Derby horse. So, what is your Kentucky ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Every Wednesday and Friday, TechNode’s Briefing newsletter delivers a roundup of the most important news in China tech, straight to your inbox. Sign up Seedance 2.0, an AI video generation model ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Months ...